Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score.

Borja Rivero-Santana Jesús Saldaña-García Juan Caro-CodónPilar ZamoraPedro MolinerAmparo Martínez MonzonisEduardo ZatarainCarlos Antonio Álvarez-OrtegaPilar Gómez-PrietoSonia PernasIsabel RodriguezAntonio Buño SotoRosalía CadenasPatricia Palacios OzoresSara Pérez RamírezMaría Merino SalvadorSilvia ValbuenaLucía Fernández GassoVictor JuárezAndrea Severo SánchezBelén TerolTeresa de Soto ÁlvarezOlaia RodríguezMaría BrionJosé González-CostelloMiguel Canales AlbendeaJosé R González-JuanateyRaúl MorenoJosé López-SendónTeresa López Fernández

Published in: European heart journal (2024)

The HFA-ICOS score effectively categorizes patients by cardiovascular toxicity risk and demonstrates strong predictive ability for high-risk anthracycline-related cardiovascular toxicity and all-cause mortality.

Keyphrases

heart failure
oxidative stress
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
palliative care
high glucose
left ventricular
oxide nanoparticles